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Recent studies suggest that epigenetic regulation (heritable changes
in gene expression that occur in the absence of alterations in DNA
sequences) may in part mediate the complex gene-by-environment
interactions that can lead to asthma. The variable natural history of
asthma (i.e., incidence and remission of symptoms) may be a result
of epigenetic changes, such as DNA methylation, covalent histone
modifications, microRNA changes, and chromatin alterations, after
early or later environmental exposures. Findings from multiple epi-
demiologic and experimental studies indicate that asthma risk may
bemodified by epigenetic regulation. One study suggested that the
transmission of asthma risk may occur across multiple generations.
Experimental studies provide substantial in vitrodata indicating that
DNAmethylation of genes critical to T-helper cell differentiationmay
induce polarization toward or away from an allergic phenotype. De-
spite this initial progress, fundamental questions remain that need
to be addressed by well-designed research studies. Data generated
from controlled experiments using in vivo models and/or clinical
specimens collected after environmental exposure monitoring are
limited. Importantly, cohort-driven epigenetic research has the po-
tential to address key questions, such as those concerning the influ-
ence of timing of exposure, dose of exposure, diet, and ethnicity on
susceptibility to asthma development. There is immense promise
that the study of environmental epigenetics will help us understand
a theoretically preventable environmental disease.
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Asthma has long been recognized as a complex genetic disease
mediated by exposures to a variety of environmental triggers. The
greater concordance of asthma among monozygotic twins when
compared with dizygotic twins demonstrates that both genetic
and environmental influences are important to asthma pathogen-
esis (reviewed inReference 1).By2007, several dozenpublications
provided evidence of specific gene-by-environment interactions
for this disease (Table 1), andmanymore can be anticipated. Yet,
the clinical presentation of asthma is heterogeneous. Some indivi-
duals are affected as young children, others as adults. Furthermore,
somedevelopasthmaorwheezing illnessasa result ofoccupational
exposures, whereas others may become affected after exposure
to urban air pollution (2, 3). Traditional models for gene-by-
environment interactions proposed in research studies have not
alwaysmatched the observations that physiciansmake in the clinic.
In 1992, theBarker hypothesis postulated that organs undergo
developmental programming in utero that predetermines sub-
sequent physiologic and metabolic adaptations during adult life.
Early (including fetal) insults after nutritional and/or environ-
mental exposures lead toagreaterpropensity to later disease (4–6).
Early support for this hypothesis included evidence that severe
fetal malnutrition was associated with an increased risk for mul-
tiple health problems throughout adulthood (5–7). Subsequent
epidemiologic and experimental studies have found associations
between the effects of a variety of prenatal environmental ex-
posures, including allergens, antibiotics, and tobacco smoke, on
disorders such as allergies, diabetes, neurodegenerative diseases,
and cardiovascular diseases (5, 7, 8). This research inspired the
fetal and early origins of adult disease hypothesis that proposes
that prenatal or early postnatal environmental exposures influ-
ence developmental plasticity and result in altered programming.
This programming is responsible for lasting functional changes of
organs that lead to the development of a variety of complex dis-
eases (reviewed in Reference 9).
Epigenetics is the study of heritable changes in gene expres-
sion that occur without directly altering the DNA sequence. One
mechanism isDNAmethylation, the covalent addition of amethyl
group to a cytosine residue in aCpGsite (i.e., where a cytosine lies
next to guanine in the DNA sequence). CpG sites generally are
clustered in high frequency near gene promoters and these re-
gions are referred to as CpG islands. The methylation states of
CpG islands in turn may affect gene activity and expression.
Another epigenetic mechanism responsible for modulation of
gene expression is post-translational modification of histones,
including, but not limited to, acetylation, methylation, phosphor-
ylation, and ubiquitylation (10, 11). Concurrent, multiple mod-
ifications of various histones create a complex pattern, often
referred to as the histone code. These modifications permit tran-
sitions between chromatin states and alterations in transcrip-
tional activity.DNAmethylationusuallyworks hand inhandwith
histone modifications to activate or silence genes by influencing
chromatin structure and stability and therefore its accessibility by
transcriptional factors (12). Both DNA methylation and histone
modification are heritable from one cell generation to the next
(13). As described by Callinan and Feinberg (12), potentially
hundreds ofmethylated cytosines inmultiple genes and dozens of
post-translational chromatin modifications can arise. Epigenetic
alterations are believed to occur predominantly prenatally and
shortly after birth. However, recent evidence suggests they can
occur during later periods (see below), influencing gene expres-
sion differentially throughout the lifespan. As such, epigenetic
regulation provides an attractive mechanistic explanation, in ad-
dition to gene-by-environment interactions, for some of the mo-
lecular events linking early exposures with later disease.
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Early seminal work performed byCooney and colleagues, and
by Waterland and Jirtle, demonstrated that dietary methyl
supplementation during pregnancy with folic acid, vitamin B12,
and other agents influenced the heritable phenotype of the agouti
mice offspring (i.e., coat color distribution) via increased CpG
methylation of the region upstream of the agouti gene (14, 15).
Subsequent research demonstrated that the early postnatal diet
induced epigenetic regulation of the imprinted gene lgf2, associ-
ated with several human cancers, in murine models (16, 17).
Additional environmental exposures implicated in epigenetic
regulation include xenobiotic chemicals, endocrine disruptors,
maternal stress and nurturing, and low-dose radiation (reviewed
in References 9 and 18). Importantly, epigenetic regulation,
particularly DNA methylation, also appears to be inherited
transgenerationally such that parental (or grandparental) expo-
sures or phenotypes impact gene expression in the offspring (or
offspring’s offspring) without changing the DNA sequence. This
phenomenon has been demonstrated for the kinked tail (AxinFu
allele) and agouti-viable yellow (Avy) allele, and for associations
between endocrine disrupters and male infertility, hormone-
dependent cancer risk, and obesity (18).
Arguably, the variable natural history of asthma (i.e., in-
cidence and remission of symptoms)may be a result of epigenetic
regulation after early or later environmental exposures (Figures 1
and 2). A large body of research has implicated specific time
periods when individuals seem to be more susceptible to the
effects of environmental exposures and other asthma triggers.
These include prenatal development, early childhood, and ado-
lescence (19–21). During these time periods, epigenetic modifi-
cations may be more likely to develop. In other work, adult rats
underwent reversal of stable epigenetic programming associated
with glucocorticoid receptor expression and hypothalamic–
pituitary–adrenal and behavioral responses to stress after expo-
sure to histone deacetylase (HDAC) inhibitors or methionine
(i.e., donor of methyl groups for DNA methylation) (22). This
study raises the question of whether adulthood, a period when
asthma often remits (23), may also be a period when critical
epigenetic changes can be deprogrammed.
This perspective will describe evidence addressing the hy-
pothesis that asthma risk may be influenced by environmentally
induced epigenetic changes. Several epidemiologic studies, includ-
ing one that suggests transmission of asthma risk after maternal
exposure to environmental tobacco smoke (ETS) may continue
across multiple generations, will be described. Experimental
studies also will be reviewed that provide substantial in vitro data
demonstrating that DNA methylation of genes critical to T-
helper (Th) differentiation may induce polarization toward or
away from an allergic phenotype. Despite this early progress,
fundamental questions remain that need to be addressed by well-
designed research studies. Currently, data generated from con-
trolled experiments using in vivomodels and/or clinical specimens
after environmental exposuremonitoringare limited. Importantly,
cohort-driven epigenetic researchhas thepotential to address key
questions, such as those concerning the influence of timing of
exposure, dose of exposure, diet, and ethnicity, on susceptibility
to asthma development.
PRENATAL ENVIRONMENTAL EXPOSURES, GENE
INTERACTIONS, AND ASTHMA RISK
A preponderance of evidence from multiple large prospective
studies indicates that prenatal exposure to ETS is associated with
impaired respiratory function, transient wheeze, asthma, and/or
respiratory infections in infants, young children, and adolescents
(24, 25). It is evident that prenatal exposure to ETS alters airway
structure, because greater distances between alveolar attach-
ments in intraparenchymal airways have been measured among
exposed infants who died of sudden infant death compared with
unexposed infants (26). This body of work provides the most
convincing evidence that prenatal environmental exposures can
influence the risk for subsequent asthma. In addition to ETS, low
maternal intake of foods containing vitamin E and zinc (27), or
use of antibiotics during pregnancy (28), may increase the risk for
childhood asthma. In contrast, maternal intake of probiotics, and
higher levels of fruits, vegetables, and oily fish during pregnancy,
may decrease the risk (29, 30). A prospective study from the
Columbia Center for Children’s Environmental Health showed
that, at age 2 years,moredifficulty breathing andprobable asthma
was reported among children jointly exposed to prenatal poly-
cyclic aromatic hydrocarbons (PAHs) and postnatal ETS (31).
Experimental animal models also have shown that intrauterine
exposure to airborne pollutants may increase the risk for re-
spiratory disease in offspring. Hamada and colleagues developed
a mouse model that demonstrated that exposure during preg-
TABLE 1. REPRESENTATIVE RESEARCH ON GENE-BY-ENVIRONMENT INTERACTIONS IN ASTHMA
OR ATOPY
Genes Environmental Exposure First author, year (reference no.)
Genomewide linkage Active smoke Dizier, 2007 (72)
Colilla, 2003 (73)
CD14 Choudhry, 2005 (74)
b2-Adrenergic receptor Wang, 2001 (75)
Genome screen Passive smoke Meyers, 2005 (76)
IL-1R Ramadas, 2007 (77)
GSTM1 In utero smoke Gilliland, 2002 (78)
TNF Ozone Li, 2006 (79)
Genomewide linkage Allergens Blumenthal, 2006 (80)
CD14 Farm Leynaert (81)
Eder, 2005 (82)
LeVan, 2005 (83)
Toll-like receptor 2 Eder, 2004 (84)
Innate immunity receptors Ege, 2006 (85)
CD14 Endotoxin Simpson, 2006 (86)
Zambelli-Weiner, 2005 (87)
Williams, 2006 (88)
b2-Adrenergic receptor Obesity Barr, 2001 (89)
IL4RA, CD-14, and IL-13 Diisocyanate Bernstein, 2006 (90)
IL-4 Helicobacter pylori infection Pessi, 2005 (91)
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nancy to residual oil fly ash (extracted from a precipitator unit
that removes particulate contaminates of an oil-fired power plant)
led to a greater susceptibility to an asthmalike phenotype in the
offspring mice, including airway hyperresponsiveness and in-
flammation, such as eosinophil infiltration and goblet cell hyper-
plasia (32). In other experimental studies, prenatal exposure to
endotoxin and probiotic bacteria protected mice against an
asthmalike phenotype (33, 34). Most recently, prenatal exposure
of mice to either diesel exhaust particles or control ‘‘inert’’ tita-
nium dioxide led to greater airway inflammation and hyper-
responsiveness in the offspring (35).
PARENT-OF-ORIGIN EFFECT
Another set of studies suggested that inheritance of particular
genetic polymorphisms from the mother is more likely to be
associated with asthma in the child than inheritance from the
father. This parent-of-origin effect points to a significant role of
thematernal prenatal environment and gene interactions on later
asthma risk in the offspring. As examples, polymorphisms in the
b-chain of the high-affinity receptor for IgE (FceRI-b) demon-
strated stronger associations with positive allergy skin prick tests
and greater allergen-specific IgE levels when they were inherited
from themother (36). In two separate cohorts, theHLA-G2964G
allele was overexpressed in children with bronchial hy-
perresponsiveness if themother was affected by bronchial hyper-
responsiveness (37). The North Staffordshire cohort of subjects
with mild asthma found that maternal, but not paternal, trans-
mission of the glutathione-S-transferase P1 (GSTP1) Val105/
Val105 and Ala114/Val114 genotypes was associated with greater
lung function (i.e., FEV1/FVC) in children. The phenotype was
not more frequent after maternal inheritance of GSTP1 Ile105/
Ile105, Ile105/Val105, orAla114/Ala114 (38).Moreover,maternal, but
not paternal, history of asthmawas associatedwith asthmaamong
children younger than 5 years (39). Maternal, but not paternal,
IgE was positively associated with elevated IgE levels in cord
blood and at age 6 months (40). The preferential association of
children’s outcomes with maternal history of asthma or elevated
IgE implies that the disease phenotype during pregnancy also
may mediate the fetal response to environmental triggers and
presumably the offspring’s subsequent asthma risk.
MULTIGENERATIONAL TRANSMISSION OF ASTHMA
Recent data also suggest that the risk of ETS exposure on asthma
may be transmitted across two generations. TheChildren’s Health
Study conducted a nested case-control study of 338 children with
asthmawho had been diagnosed by age 5 years versus 570 control
subjects who were matched on in utero exposure to maternal
smokingwithin grade, sex, and community of residence.Maternal
and household smoking histories were obtained by telephone
interviews. Grandmaternal smoking during the mother’s fetal
periodmay have been associated with a greater asthma risk in the
grandchildren, independentofmaternal smoking (odds ratio [OR],
1.8; 95% confidence interval [CI], 1.0–3.3). The risk for asthma in
grandchildren was heightened if both the grandmother and
mother smoked during pregnancy (OR, 2.6; 95% CI, 1.6–4.5)
Figure 1. Environmental epige-
netics and asthma. Red circles re-
fer to sites of epigenetic changes.
ETS 5 environmental tobacco
smoke.
Figure 2. Epigenetic and genetic interactions influence interindividual
asthma risk.
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(41). Although much of the data were collected retrospectively,
the findings lend support to the possibility that environmental
exposures may alter asthma risk across generations.
EARLY POSTNATAL ENVIRONMENTAL EXPOSURES AND
BOTH EARLY- AND LATE-ONSET ASTHMA RISK
In addition to prenatal exposures, multiple cohort studies suggest
that early postnatal exposuresmodify the risk for developing later
childhoodor adult-onset asthma.As anexample, exposure todust
mite allergenduring infancymaybe an important determinant for
later childhood asthma (42). Exposure to dog or cat allergen is
associated with protection from later childhood wheeze in some
(43), but not all (44), cohort studies. Exposure during infancy to
indoor combustion-related pollutants has been associated with
later childhood sensitization to dustmite and a reduction in FEV1
(45). Despite these associations between early postnatal environ-
mental exposures and later disease, direct links to epigenetic
mechanisms have not been established to date.
The links between early environmental exposure and adult-
onset asthma are even more indirect, but several studies suggest
possible relationships. Very low birth weight and prematurity,
two disease phenotypes that have been associated with prenatal
exposure to pollutants such as ETS and PAHs (46, 47), were
associated with reduced FEF25–75% (forced expiratory flow, mid-
expiratory phase) FEV1/FVC, chronic cough, wheeze, and asthma
during subsequent adolescence (48). Two other studies reported
that respiratory infections during infancy were associated in-
dependently with a greater incidence of chronic obstructive lung
disease (49, 50). Combined, both studies point to an enduring ef-
fect of adverse environmental conditions experienced during
fetaldevelopment (i.e., duringgrowthofairways) and shortly after-
ward (during expansion of alveoli). Therefore, exposures during
either of these critical periods for lung development appear to
affect the risk for developing asthma at later life stages, including
during childhood and later adulthood.
PROPOSED EPIGENETIC MECHANISMS
The traditional view that interindividual risk for asthma, like
other complex diseases, is determined solely by interactions
between genetic polymorphisms and environmental exposures
needs to be reconciled with new findings suggesting that epige-
netic mechanisms also may contribute. These mechanisms in-
clude genomic imprinting, histone modification, altered DNA
methylation of regulatory sequences in Th and other genes, and
regulation by microRNA (miRNA), which may change asthma
risk after conception via environmentally mediated epigenetic
disruption of gene expression (18). In genomic imprinting, un-
equal expression of the maternal and paternal alleles occurs,
presumably due to reversible modification of gene activity in
association with the sex of the parent. Differential DNA meth-
ylation of promoter regions of reprogrammable genes may be an
important mechanism in establishing the imprint (reviewed in
Reference 51). For example, infections incurred during preg-
nancy have been hypothesized to transmit transgenerationally
the imprints of infections and inflammation, reduce the off-
spring’s ability to withstand environmental pathogens, and in
turn impact later morbidity and mortality (52). Direct mechanis-
tic links to asthma pathogenesis still need to be determined.
Another proposed mechanism is induction of histone mod-
ifications, a process that is reversible and may be associated with
chromatin remodeling and gene transcription.Oxidant-generating
systems and proinflammatory mediators, some of which are im-
plicated in asthma, may regulate histone acetylation (53). As an
example, exposure toH2O2 (a reactive oxygen species) caused an
increase in histone acetyltransferase (HAT) activity that pro-
moted acetylation and induced chromatin remodeling (53). In
other work, untreated subjects with asthma possessed greater
levels of HAT and reduced levels of HDACs in bronchial
biopsies, with levels that reversed after treatment with inhaled
steroids (54). In addition, endotoxin exposure, associated with
protection from developing atopy or asthma in several studies
(55, 56), binds histones. It may disrupt chromatin remodeling as
well and participate in gene silencing. The evidence is the finding
in a septicemia cell model in which endotoxin exposure altered
nuclear factor-kB binding and chromatin remodeling of the
proinflammatory gene IL-1b promoter nucleosome (57).
Methylation of DNA and resulting changes in chromatin
structure have been shown to initiate the process by which the
Th cells lose their plasticity and differentiate productively toward
the Th1 versus the proallergic Th2 pattern of cytokine gene
expression. Demethylation of sites at the proximal promoter and
conserved intronic regulatory element (CIRE) in the first intron
of the proallergic IL-4 gene, and hypermethylation of sites in the
counterregulatory IFN-g promoter, all result in greater IL-4 pro-
duction and Th2 differentiation (58–61). Methylation of a highly
conserved DNaseI-hypersensitive region at the 39 end of IL-4 is
associatedwithTh1differentiation (58). Interestingly,manyCpG
sites found in Th genes are highly conserved across species, in-
cluding CpG253 and CpG2190 of the IFN-g promoter (61, 62).
CpG253 resides in a proximal activator protein 1 (AP1)-binding
site, and when methylated, can change transcription factor
binding (63). In addition, methylation of CpG253 in the IFN-g
promoter was associated with Th2 polarization after inhibition of
cAMP response element binding protein (CREB) and activating
transcription factor 2 (ATF2)/c-Jun binding to the CpG-contain-
ing AP1 site (61). Therefore, mounting evidence from in vitro
experimental studies suggests that thedevelopment of apolarized
Th2 phenotype associated with atopy may result from altered
DNA methylation at genes regulating Th differentiation. More-
over, recent work by our group demonstrated that inhaled diesel
exposure and intranasal Aspergillus fumigatus induced hyper-
methylation at the CpG245, CpG253, and CpG2205 sites of the
IFN-g promoter and hypomethylation at CpG2408 of the IL-4
promoter in mice. Altered methylation of both gene promoters
was correlated significantly with changes in IgE levels, suggesting
that inhaled environmental exposures can induce methylation of
Th genes and IgE regulation in vivo (64). In addition, ETS has
been shown to induce gene hypermethylation in a gene associated
with lung cancer (i.e., p16 [INK4a] tumor suppressor gene involved
in cell cycle control) (65). Whether these observations occur in
association with clinical asthma still needs to be elucidated.
A rapidly emerging area of epigenetics research relates to the
role played bymiRNA in regulating asthma-related gene expres-
sion. Since the first miRNA, Lin 4, was discovered in 1993 (66),
over 300 miRNAs have been identified in humans. Each miRNA
may regulate up to 200 target genes by blocking the translation of
the target protein (67). These molecules are believed to regulate
up to one-third of all human genes by promoting the degradation
of target messenger RNA. Aberrant expression of miRNA has
been shown to contribute to the pathogenesis of many human
diseases and may serve as valuable diagnostic or prognostic dis-
easemarkers (68).However, studies relevant to asthmaor asthma
risk are still lacking, except for a recent report demonstrating that
a single nucleotide polymorphism at the 39 untranslated region of
HLA-G, an asthma-susceptibility gene, affects the binding of
threemiRNAs to this gene (69, 70). This report raises the exciting
possibility of a gene-by-epigenetics interaction. Perhaps future
discoveries will implicate specific environmental exposures that
might disrupt miRNA expression patterns in cells and tissues rel-
evant to asthma pathogenesis.
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WHAT ARE THE KEY RESEARCH QUESTIONS?
The first important question for epigenetic studies is to determine
whether any in vivo environmental exposure can induce epige-
netic alterations that underlie asthma. The clinical presentation
of asthma is mediated by exposure to allergens, air pollutants,
endotoxin, viruses, andETS.Which of these are important?What
are the effects of exposure dose or diet (i.e., methyl donors)?
Second, when are the time periods during fetal development
and afterward when individuals are more susceptible to epige-
netic modifications that influence the clinical course of asthma?
How do they differ by environmental exposure, and how do they
explain the induction or remission of asthma that is observed at
different time points and ages? Can epigenetic changes be re-
versed?
Third, how do genetics and epigenetics interact? For exam-
ple, how do polymorphisms in asthma-related genes, many of
which have been identified (Table 1), interact with epigenetic
mechanisms to confer heightened susceptibility to environmen-
tal influences?
Fourth, can epigenetic changes providemeasurablebiomarkers
that may predict later asthma and greater need for immediate in-
tervention? Can one identify an epigenome that is susceptible to,
for example, air pollution–related asthma, and enact specific inter-
ventions to reduce asthma risk?
POTENTIAL APPROACHES TO FUTURE
EPIGENETIC STUDIES
Both in vivo experimental animal models and cohort-driven
epigenetic research have great potential to answer many of the
above questions. Mouse models may provide the experimental
controls needed to examine the main effects of a variety of air-
borne exposures, including allergens and air pollutants, on selected
candidate asthma genes. The modifying effects of diet enriched
with methyl donors or HDAC inhibitors also can be tested. In
addition, mice of different genetic background and those with
unique transgenes could illuminate further these issues.
More exciting may be the potential to apply newly developing
technologies to epidemiologic studies. Longitudinal cohort studies
that feature repeated measures of specific environmental expo-
sures, collection of biological specimens over time, and compre-
hensive clinical outcomes assessment have enormous potential to
add a wealth of information on specific environmental triggers
and critical time windows of susceptibility. In partnership with
global, unbiased screeningmethods, such as methylation-sensitive
restriction fingerprinting, restriction landmark genomic scanning,
methylation of CpG island amplification–representational differ-
ence analysis, and methylation target microarrays to identify
candidate regions, as well as validation assays to reassess genes of
interest (71), epigenomes susceptible toETS-induced asthma, for
example, may be identifiable in the near future.
It is unlikely that any individual study will be able to account
for all of the potentially confounding factors, limiting one’s
ability to examine epigenetic pathways in observational studies.
These include environment-by-environment interactions, tradi-
tional gene-by-environment interactions, effects of birth order,
and other host factors such as obesity. Despite these limitations,
there is great promise that the study of environmental epige-
netics will help us understand a theoretically preventable envi-
ronmental disease.
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